I agree that this site is using cookies. You can find further informations here.
X
Venugopal, Sangeetha
33  results:
OpenAccess-fulltext X
Search for persons X
?
1

The future paradigm of HMA + VEN or targeted inhibitor appr..:

Venugopal, Sangeetha ; Watts, Justin
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10727059/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN CO..:

Bataller, Alex ; Bazinet, Alexandre ; Venugopal, Sangeetha...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428441/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Olutasidenib: from bench to bedside:

Venugopal, Sangeetha ; Watts, Justin
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432604/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

P723: CLINICAL AND MOLECULAR ASSOCIATIONS WITH OUTCOMES IN ..:

Bazinet, Alexandre ; Prasad Desikan, Sai ; LI, Ziyi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429244/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Targeted therapy with the mutant IDH2 inhibitor enasidenib ..:

DiNardo, Courtney D ; Venugopal, Sangeetha ; Lachowiez, Curtis...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220255/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Clinical outcomes associated with NPM1 mutations in patient..:

Issa, Ghayas C ; Bidikian, Aram ; Venugopal, Sangeetha...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027507/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
7

Validation of ALFA 1200 score in patients with AML >60 year..:

Venugopal, Sangeetha ; Borthakur, Gautam ; Daver, Naval...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647734/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

Impact of frontline treatment approach on outcomes in patie..:

Short, Nicholas J ; Venugopal, Sangeetha ; Qiao, Wei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800349/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Efficacy and safety of enasidenib and azacitidine combinati..:

Venugopal, Sangeetha ; Takahashi, Koichi ; Daver, Naval...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789767/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Decitabine and Venetoclax for IDH1/2-mutated Acute Myeloid ..:

Venugopal, Sangeetha ; Maiti, Abhishek ; DiNardo, Courtney D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237705/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

FLT3 mutated acute myeloid leukemia: 2021 treatment algorit..:

Daver, Naval ; Venugopal, Sangeetha ; Ravandi, Farhad
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159924/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Novel therapeutics in myeloproliferative neoplasms:

Venugopal, Sangeetha ; Mascarenhas, John
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709419/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
13

Ibrutinib‐induced severe liver injury:

Nandikolla, Amara G ; Derman, Olga ; Nautsch, Deborah...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458017/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
14

Catheter-associated Urinary Tract Infections Prevention: Ph..:

Singh, Supriya ; Venugopal, Sangeetha ; Saeed, Muhammad.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630851/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
15

Breast cancer in patients with Li–Fraumeni syndrome – a cas..:

Nandikolla, Amara G ; Venugopal, Sangeetha ; Anampa, Jesus
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367777/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
1-15